# Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death

> **NCT04914832** · PHASE4 · COMPLETED · sponsor: **Shabir Madhi** · enrollment: 75012 (actual)

## Conditions studied

- COVID-19
- Pneumonia, Viral

## Interventions

- **BIOLOGICAL:** AZD1222

## Key facts

- **NCT ID:** NCT04914832
- **Lead sponsor:** Shabir Madhi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-30
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 75012 (ACTUAL)
- **Last updated:** 2023-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04914832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04914832, "Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04914832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*